EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY 4.0

Effect of Helicobacter pylori eradication on remnant stomach neoplasms after curative gastrectomy (HELP-GC): Protocol of a HELP-GC randomized controlled trial

Chang Seok Ko, Jin Hee Noh, Young Soo Park, Jeong Hwan Yook, Hwoon-Yong Jung, In-Seob Lee iD, Ji Yong Ahn, Ji Sung Lee

PLOS One · 2025

DOI: 10.1371/journal.pone.0320903 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2025. Verfasst von Chang Seok Ko und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastrointestinal Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Gastrectomy, Gastric Stump, Helicobacter Infections. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea, Hanmi pharmaceutical Co.,Ltd, sponsored research funds provided by Mr. Hyeonho Kim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Limited research has examined the direct effectiveness of Helicobacter pylori eradication (HPE) on the remnant stomach neoplasms after curative gastrectomy. This study aims to assess whether HPE could prevent the development of gastric neoplasms in the remnant stomach after curative gastrectomy through a double-blinded, randomized controlled trial.

Methods

After curative gastrectomy, patients with HP infection and pathologically proven stage 1 tumors will be enrolled and randomly assigned to eradication (n = 492) and placebo (n = 492) groups. Patients in the eradication arm will be given the eradication regimen, which will comprise 40 mg of esomeprazole, 1 g of amoxicillin, and 500 mg of clarithromycin twice a day for 14 days. The primary endpoint is the development of gastric neoplasms, including adenoma or adenocarcinoma. The secondary endpoints are the 10-year overall survival, improvement rates of gastric glandular atrophy and/or intestinal metaplasia, and incidence of new-onset hyperplastic polyps among the groups. Significance This research will be the first randomized controlled clinical study in which a thorough long-term follow-up will be needed to evaluate the effectiveness of HPE for remnant stomach neoplasms after curative gastrectomy. Its results will serve as a basis for developing future strategies in the management of patients with HP infection who undergo curative gastrectomy. Trial registration https://cris.nih.go.kr/ KCT0008855. October 10, 2023.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsGastrectomyGastric StumpHelicobacter InfectionsHelicobacter pyloriStomach NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedAmoxicillinClarithromycinDouble-Blind MethodEsomeprazoleRandomized Controlled Trials as Topic

Substanzen

AmoxicillinAnti-Bacterial AgentsClarithromycinEsomeprazole

Autor:innen und Institutionen

  • Division of Gastrointestinal Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea.
  • Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Division of Gastroenterology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: In-Seob Lee

Förderung

  • Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea
  • Hanmi pharmaceutical Co.,Ltd
  • sponsored research funds provided by Mr. Hyeonho Kim

Zitieren

APA

Ko, C. S., Noh, J. H., Park, Y. S., Yook, J. H., Jung, H. Y., Lee, I. S., Ahn, J. Y., & Lee, J. S. (2025). Effect of Helicobacter pylori eradication on remnant stomach neoplasms after curative gastrectomy (HELP-GC): Protocol of a HELP-GC randomized controlled trial. PLOS One. https://doi.org/10.1371/journal.pone.0320903

Vancouver

Ko CS, Noh JH, Park YS, Yook JH, Jung HY, Lee IS, et al. Effect of Helicobacter pylori eradication on remnant stomach neoplasms after curative gastrectomy (HELP-GC): Protocol of a HELP-GC randomized controlled trial. PLOS One. 2025. doi:10.1371/journal.pone.0320903

BibTeX
@article{Ko2025,
  author = {Ko, Chang Seok and Noh, Jin Hee and Park, Young Soo and Yook, Jeong Hwan and Jung, Hwoon-Yong and Lee, In-Seob and Ahn, Ji Yong and Lee, Ji Sung},
  title = {Effect of Helicobacter pylori eradication on remnant stomach neoplasms after curative gastrectomy (HELP-GC): Protocol of a HELP-GC randomized controlled trial},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0320903}
}
Kostenlos starten →